Skip to main content
. 2020 Apr 21;2020:1847061. doi: 10.1155/2020/1847061

Table 4.

Clinical efficacy after short-term SLIT.

Effective group Ineffective group
3 months of SLIT
 Cases 271 (58%) 195 (42%)
 Endpoint symptoms 2.6 ± 1.2 6.5 ± 2.7
 Endpoint medication 3.7 ± 2.1 7.3 ± 3.6
 SMS 7.8 ± 3.5 12.9 ± 4.3
6 months of SLIT
 Cases 303 (65%) 163 (35%)
 Endpoint symptoms 2.4 ± 1.1 6.7 ± 2.8
 Endpoint medication 3.1 ± 1.8 7.5 ± 3.4
 SMS 6.9 ± 3.6 13.2 ± 4.6

aData presented as median values (minimum-maximum). Compared with the control group, P < 0.05.